Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.
about
Immunological weapons against acute myeloid leukaemia.DNA fusion gene vaccines against cancer: from the laboratory to the clinic.HLA-A2-restricted cytotoxic T lymphocyte epitopes from human heparanase as novel targets for broad-spectrum tumor immunotherapy.Antitumor effect of new multiple antigen peptide based on HLA-A0201-restricted CTL epitopes of human telomerase reverse transcriptase (hTERT).
P2860
Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.
@ast
Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.
@en
Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.
@nl
type
label
Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.
@ast
Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.
@en
Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.
@nl
prefLabel
Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.
@ast
Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.
@en
Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.
@nl
P2093
P2860
P1433
P1476
Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.
@en
P2093
Anderson KS
Vonderheide RH
von Bergwelt-Baildon MS
P2860
P356
10.1046/J.1423-0410.2001.00014.X
P577
2001-02-01T00:00:00Z